Floatz logo

rg4733

Recurrent Adult Unclassified Pleomorphic Sarcoma of Bone

National Cancer Institute (NCI)Phase 1/2Dormant
CC
41/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
26/ 100
Competitive Position
95/ 100

Competitive context

5 Active assets in the Recurrent Adult Unclassified Pleomorphic Sarcoma of Bone cohort.

Asset / SponsorPhaseRating
Lifileucel
M.D. Anderson Cancer Center
Phase 2CCC
Ipilimumab
M.D. Anderson Cancer Center
Phase 2CCC
Fludarabine
M.D. Anderson Cancer Center
Phase 2CCC
Nivolumab
M.D. Anderson Cancer Center
Phase 2CCC
Cyclophosphamide
M.D. Anderson Cancer Center
Phase 2CCC
Gdc-0449
National Cancer Institute (NCI)
Phase 1/2CCC
Glutamine
Children's Oncology Group
N/AD

Same molecule, other indications

rg4733 is also rated in:

non-small cell lung carcinomaDormant
CCC
Indicative ·
51 / 100
View asset →
melanomaDormant
CCC
Indicative ·
51 / 100
View asset →
Stage IV Skin MelanomaDormant
CCC
Indicative ·
51 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →